+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Real-time PCR (qPCR) & Digital PCR (dPCR) Market Size, Share & Trends Analysis By Technology (Quantitative, Digital), By Product (Consumables, Instruments), By Application, And Segment Forecasts, 2019 - 2026

  • ID: 4396497
  • Report
  • May 2019
  • Region: Global
  • 110 pages
  • Grand View Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • biomérieux S.A.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Fluidigm Corporation
  • GE Healthcare
  • MORE
The global real-time pcr and digital pcr market size is anticipated to reach USD 4.33 billion by 2026, according to this report. It is anticipated to register a CAGR of 8.5% during the forecast period. Growing demand for Rapid Diagnostics Tests (RTDs) is one of the high impact rendering drivers for this market. The demand for RDTs is likely to witness strong growth as local governments across the globe seek to incorporate these tests to improve the diagnosis and treatment of infectious diseases.

The emergence of RDTs as an important tool in the management of infectious diseases owing to the ability to provide rapid results in remote areas with limited healthcare infrastructure is likely to fuel the growth of the Polymerase Chain Reaction (PCR) systems which are used extensively to conduct these diagnostic procedures.

In addition, high prevalence of infectious diseases is one of the major factors contributing to the market growth. According to the estimates by the World Health Organization (WHO), lower respiratory infections, diarrheal diseases, and tuberculosis were ranked among the top ten causes of deaths worldwide in 2016. New cases of other infectious diseases, such as HIV/AIDS and malaria among others continue to witness sharp increase in developing countries which is expected to substantially increase the patient population, driving the need for better diagnosis options.

Furthermore, inorganic growth strategies such as mergers and acquisitions employed by major PCR manufacturers to broaden their product portfolio and to develop novel qPCR and dPCR products is another factor expected to propel the market during the forecast period. For instance, in January 2017, RainDance Technologies, Inc. was acquired by Bio-Rad Laboratories, Inc. which is expected to strengthen the company’s position in the field of droplet digital PCR and next generation sequencing.

Further key findings from the report suggest:
  • qPCR held the largest market share in 2018 due to the accuracy and wide applications of the technology in quantification of gene expression, pathogen detection and microRNA analysis
  • Digital PCR is estimated to be the fastest growing segment due to precise quantification of target sequences
  • Consumables and reagents led the product segment and is likely register the fastest CAGR of 8.9% over the forecast period due strong uptake in the use of PCR kits in diagnostic tests
  • Research application was the largest segment in terms of value in 2018, due to wide-spread use in research areas, such as stem cells, microbiology, and agriculture
  • Clinical application is expected to witness robust growth over the forecast period due to the adoption of automated processes
  • North America held the largest market share in terms of revenue in 2018 due launch of new PCR products along with rising demand for rapid diagnostic tests
  • Asia Pacific is projected to register comparatively strong growth during the forecast period owing to burgeoning patient population as a result of prevalence of infectious diseases
  • Prominent players in the qPCR and dPCR market include Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Abbott Laboratories, Inc., and others

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • biomérieux S.A.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Fluidigm Corporation
  • GE Healthcare
  • MORE
Chapter 1 Methodology And Scope
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources & Third Party Perspectives
1.3.4 Primary Research
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market formulation & data visualization
1.6 Data Validation & Publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Industry Value Chain Analysis
3.3.1 User Perspective Analysis
3.3.1.1 Consumer Behavior Analysis
3.3.1.2 Market Influencer Analysis
3.4 Technology Overview
3.4.1 Technology Timeline
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.2 Market Restraint Analysis
3.6 Real time PCR (qPCR) and digital PCR (dPCR) Market Analysis tools
3.6.1 Industry Analysis - Porter’s
3.6.1.1 Supplier Power (low; large number of small scale suppliers)
3.6.1.2 Buyer Power (High; high adoption of advanced technology)
3.6.1.3 Substitution Threat (Moderate; frequent new product launches)
3.6.1.4 Threat from new entrant (Moderate; stringent norms to restrict entrants)
3.6.1.5 Competitive rivalry (High; consolidated market)
3.6.2 PESTEL Analysis
3.6.2.1 Political Landscape
3.6.2.2 Environmental Landscape
3.6.2.3 Social Landscape
3.6.2.4 Technology Landscape
3.6.2.5 Legal Landscape
3.6.3 Major Deals & Strategic Alliances Analysis
3.6.3.1 Joint Ventures
3.6.3.2 Mergers & Acquisitions
3.6.3.3 Licensing & Partnership
3.6.3.4 Technology Collaborations
3.6.3.5 Strategic Divestments
3.6.4 Market Entry Strategies
3.6.5 Case Studies

Chapter 4 Real time PCR (qPCR) and digital PCR (dPCR) Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.2 Vendor Landscape
4.2.1 List of Key Distributors and Channel Partners
4.2.2 Key Company Market Share Analysis, 2018
4.3 Public Companies
4.3.1 Company Market Position Analysis
4.3.2 Competitive Dashboard Analysis
4.4 Private Companies
4.4.1 List of Key Emerging Companies’ /Technology Disruptors/Innovators
4.4.2 Regional Network Map

Chapter 5 Real time PCR (qPCR) and digital PCR (dPCR) Market: Technology Estimates and Trend Analysis
5.1 Definition and Scope
5.2 Technology Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 Global Real time PCR (qPCR) and digital PCR (dPCR) Market, by Technology, 2014 - 2026 (USD Million)
5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026, by Technology
5.5.1 Quantitative
5.5.1.1 Quantitative Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)
5.5.2 Digital
5.5.2.1 Digital Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)

Chapter 6 Real time PCR (qPCR) and digital PCR (dPCR) Market: Product Estimates and Trend Analysis
6.1 Definition and Scope
6.2 Product Market Share Analysis, 2018 & 2026
6.3 Segment Dashboard
6.4 Global Real time PCR (qPCR) and digital PCR (dPCR) Market, by Product, 2014 - 2026 (USD Million)
6.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026, by Product
6.5.1 Consumables and Reagents
6.5.1.1 Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)
6.5.1.2 Market Size & Forecasts and Trend Analyses, by Technology 2014 to 2026 (USD Million)
6.5.2 Instruments
6.5.2.1 Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)
6.5.2.2 Market Size & Forecasts and Trend Analyses, by Technology 2014 to 2026 (USD Million)
6.5.3 Software & Services
6.5.3.1 Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)
6.5.3.2 Market Size & Forecasts and Trend Analyses, by Technology 2014 to 2026 (USD Million)

Chapter 7 Real time PCR (qPCR) and digital PCR (dPCR) Market: Application Estimates and Trend Analysis
7.1 Definition and Scope
7.2 Application Market Share Analysis, 2018 & 2026
7.3 Segment Dashboard
7.4 Market, by Application, 2014 - 2026 (USD Million)
7.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026, by Application
7.5.1 Clinical
7.5.1.1 Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)
7.5.1.2 Market Size & Forecasts and Trend Analyses, by Technology 2014 to 2026 (USD Million)
7.5.1.3 Market Size & Forecasts and Trend Analyses, by Technology 2014 to 2026 (USD Million)
7.5.1.4 Market Size & Forecasts and Trend Analyses, by Technology 2014 to 2026 (USD Million)
7.5.1.5 Market Size & Forecasts and Trend Analyses, by Technology 2014 to 2026 (USD Million)
7.5.2 Research
7.5.2.1 Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)
7.5.3 Forensics
7.5.3.1 Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)

Chapter 8 Real time PCR (qPCR) and digital PCR (dPCR) Market Regional Estimates & Trend Analysis, by Technology, Product & Application
8.1 Regional Market Snapshot
8.2 Market Share Analysis by Country
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa
8.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Latin America
8.3.5 Middle East & Africa
8.4 Market Size, & Forecasts and Trend Analysis, 2014 to 2026
8.5 North America
8.5.1 North America Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.5.2 U.S.
8.5.2.1 U.S. Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.5.3 Canada
8.5.3.1 Canada Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.6 Europe
8.6.1 Europe Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.6.2 U.K.
8.6.2.1 U.K. Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.6.3 Germany
8.6.3.1 Germany Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.6.4 Italy
8.6.4.1 Italy Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.6.5 Spain
8.6.5.1 Spain Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.6.6 France
8.6.6.1 France Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.6.7 Russia
8.6.7.1 Russia Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.7 Asia Pacific
8.7.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.7.2 China
8.7.2.1 China Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.7.3 Japan
8.7.3.1 Japan Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.7.4 India
8.7.4.1 India Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.7.5 Australia
8.7.5.1 Australia Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.7.6 South Korea
8.7.6.1 South Korea Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.7.7 Singapore
8.7.7.1 Singapore Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.8 Latin America
8.8.1 Latin America Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.8.2 Brazil
8.8.2.1 Brazil Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.8.3 Mexico
8.8.3.1 Mexico Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.8.4 Argentina
8.8.4.1 Argentina Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.9 Middle East and Africa
8.9.1 Middle East and Africa Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.9.2 South Africa
8.9.2.1 South Africa Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.9.3 Saudi Arabia
8.9.3.1 Saudi Arabia Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)
8.9.4 UAE
8.9.4.1 UAE Market Size, & Forecasts and Trend Analysis, 2014 to 2026 (USD Million)

Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 Bio-Rad Laboratories Inc.
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 Agilent Technologies, Inc.
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 GE Healthcare
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 biomérieux S.A.
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 F. Hoffmann-La Roche Ltd
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Fluidigm Corporation
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives

*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 4
  • Abbott Laboratories
  • Qiagen N.V.
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • biomérieux S.A.
  • F. Hoffmann-La Roche Ltd
  • Fluidigm Corporation
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll